155 related articles for article (PubMed ID: 1468911)
1. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.
Fogelholm R; Murros K
Headache; 1992 Nov; 32(10):509-13. PubMed ID: 1468911
[TBL] [Abstract][Full Text] [Related]
2. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
Saper JR; Lake AE; Cantrell DT; Winner PK; White JR
Headache; 2002 Jun; 42(6):470-82. PubMed ID: 12167135
[TBL] [Abstract][Full Text] [Related]
3. An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache.
Saper JR; Winner PK; Lake AE
Headache; 2001 Apr; 41(4):357-68. PubMed ID: 11318882
[TBL] [Abstract][Full Text] [Related]
4. Modified-release formulation of tizanidine in chronic tension-type headache.
Murros K; Kataja M; Hedman C; Havanka H; Säkö E; Färkkilä M; Peltola J; Keränen T
Headache; 2000 Sep; 40(8):633-7. PubMed ID: 10971659
[TBL] [Abstract][Full Text] [Related]
5. Treatment of tension-type headache with tizanidine hydrochloride: its efficacy and relationship to the plasma MHPG concentration.
Shimomura T; Awaki E; Kowa H; Takahashi K
Headache; 1991 Oct; 31(9):601-4. PubMed ID: 1774177
[TBL] [Abstract][Full Text] [Related]
6. Effects of tizanidine administration on exteroceptive suppression of the temporalis muscle in patients with chronic tension-type headache.
Nakashima K; Tumura R; Wang Y; Shimoda M; Sakuma K; Takahashi K
Headache; 1994 Sep; 34(8):455-7. PubMed ID: 7960728
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
[TBL] [Abstract][Full Text] [Related]
8. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
[TBL] [Abstract][Full Text] [Related]
9. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
[TBL] [Abstract][Full Text] [Related]
10. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
Freitag FG
CNS Drugs; 2003; 17(6):373-81. PubMed ID: 12696998
[TBL] [Abstract][Full Text] [Related]
11. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.
Bes A; Eyssette M; Pierrot-Deseilligny E; Rohmer F; Warter JM
Curr Med Res Opin; 1988; 10(10):709-18. PubMed ID: 3286129
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis.
Nance PW; Sheremata WA; Lynch SG; Vollmer T; Hudson S; Francis GS; O'Connor P; Cohen JA; Schapiro RT; Whitham R; Mass MK; Lindsey JW; Shellenberger K
Arch Neurol; 1997 Jun; 54(6):731-6. PubMed ID: 9193208
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
Smolenski C; Muff S; Smolenski-Kautz S
Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
[TBL] [Abstract][Full Text] [Related]
14. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
Wallace JD
Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of neuroprotectors in patients with tension headaches.
Medvedeva LA; Gnezdilov AV; Zagorul'ko OI; Syrovegin AV; Samoilova NV
Neurosci Behav Physiol; 2007 Jun; 37(5):523-6. PubMed ID: 17505806
[TBL] [Abstract][Full Text] [Related]
16. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain.
Berry H; Hutchinson DR
J Int Med Res; 1988; 16(2):75-82. PubMed ID: 2967780
[TBL] [Abstract][Full Text] [Related]
17. Spasmodic torticollis: treatment with Tizanidine.
ten Houten R; Lakke JP; de Jong P; van Weerden TW; van den Burg W; Wesseling H
Acta Neurol Scand; 1984 Nov; 70(5):373-6. PubMed ID: 6391067
[TBL] [Abstract][Full Text] [Related]
18. Tizanidine for the management of acute postoperative pain after inguinal hernia repair: A placebo-controlled double-blind trial.
Yazicioğlu D; Caparlar C; Akkaya T; Mercan U; Kulaçoğlu H
Eur J Anaesthesiol; 2016 Mar; 33(3):215-22. PubMed ID: 26555871
[TBL] [Abstract][Full Text] [Related]
19. Amitriptyline in the treatment of headache in patients with Parkinson's disease: a double-blind placebo-controlled study.
Indaco A; Carrieri PB
Neurology; 1988 Nov; 38(11):1720-2. PubMed ID: 3054626
[TBL] [Abstract][Full Text] [Related]
20. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.
Manna V; Bolino F; Di Cicco L
Headache; 1994 Jan; 34(1):44-9. PubMed ID: 8132440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
